Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

SHE:301281 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	448.83	457.46	445.94	442.31	419.67	365.95
Other Revenue	5.61	6.26	1.64	0.55	1.22	1.11
Revenue	454.44	463.72	447.58	442.87	420.89	367.06
Revenue Growth (YoY)	-1.26%	3.60%	1.06%	5.22%	14.67%	18.02%
Cost of Revenue	228.58	266.76	240.86	264.82	246.14	187.25
Gross Profit	225.86	196.96	206.73	178.04	174.75	179.81
Selling, General & Admin	130.66	116.12	99.72	56.03	63.1	71.71
Research & Development	39.09	35.82	43.86	26.97	24.43	27.84
Other Operating Expenses	1.2	4.19	4.36	5.3	4.47	5.33
Operating Expenses	172.38	156.42	148.25	89.14	92.11	103.96
Operating Income	53.47	40.54	58.48	88.91	82.64	75.85
Interest Expense	-0.05	-0.04	-	-	-	-1.83
Interest & Investment Income	11.86	15.4	15.97	1.33	0.96	0.11
Currency Exchange Gain (Loss)	-0.56	-0.59	1.15	1.55	-1.11	-0.55
Other Non Operating Income (Expenses)	4.39	-2.03	0.09	-0.32	0.05	-0.38
EBT Excluding Unusual Items	69.11	53.29	75.7	91.47	82.55	73.2
Gain (Loss) on Sale of Investments	0.48	0.8	0.54	-	-	-
Gain (Loss) on Sale of Assets	-0.37	-0.84	0.04	0.37	-0.04	-0.09
Asset Writedown	-2.59	-	-	-	-	-
Legal Settlements	-0.14	-0.14	-	-	-	-
Other Unusual Items	2.26	12.61	3.45	6.47	7.41	7.97
Pretax Income	68.74	65.71	79.74	98.3	89.92	81.08
Income Tax Expense	1.85	5.44	2.7	7.02	11.75	12.43
Net Income	66.87	60.27	77.04	91.28	78.17	68.65
Net Income to Common	66.87	60.27	77.04	91.28	78.17	68.65
Net Income Growth	8.00%	-21.77%	-15.60%	16.77%	13.87%	127.73%
Shares Outstanding (Basic)	108	108	101	81	81	81
Shares Outstanding (Diluted)	108	108	101	81	81	81
Shares Change (YoY)	-0.45%	6.18%	24.38%	0.53%	-0.47%	0.34%
EPS (Basic)	0.62	0.56	0.76	1.12	0.96	0.84
EPS (Diluted)	0.62	0.56	0.76	1.12	0.96	0.84
EPS Growth	8.49%	-26.32%	-32.14%	16.15%	14.40%	126.95%
Free Cash Flow	-276.78	-356.9	-33.12	84.75	31.83	98.04
Free Cash Flow Per Share	-2.57	-3.32	-0.33	1.04	0.39	1.20
Dividend Per Share	0.200	0.200	0.300	0.286	-	-
Dividend Growth	-33.33%	-33.33%	5.00%	-	-	-
Gross Margin	49.70%	42.47%	46.19%	40.20%	41.52%	48.99%
Operating Margin	11.77%	8.74%	13.06%	20.08%	19.63%	20.66%
Profit Margin	14.71%	13.00%	17.21%	20.61%	18.57%	18.70%
Free Cash Flow Margin	-60.91%	-76.96%	-7.40%	19.14%	7.56%	26.71%
EBITDA	101.21	83.84	107.43	122.54	109.5	101.2
EBITDA Margin	22.27%	18.08%	24.00%	27.67%	26.02%	27.57%
D&A For EBITDA	47.74	43.3	48.95	33.63	26.86	25.35
EBIT	53.47	40.54	58.48	88.91	82.64	75.85
EBIT Margin	11.77%	8.74%	13.06%	20.08%	19.63%	20.66%
Effective Tax Rate	2.69%	8.27%	3.38%	7.14%	13.06%	15.33%
Revenue as Reported	545.31	463.72	447.58	442.87	420.89	367.06
Advertising Expenses	-	4.03	1.89	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.